Skip to content

CoolSculpting of the Flank With Alternate Treatment Parameters

Non-Invasive Reduction of Subcutaneous Fat Layer With an Alternative Treatment Parameter

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02081196
Enrollment
45
Registered
2014-03-07
Start date
2014-02-18
Completion date
2014-06-27
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Fat Disorder

Keywords

Lipolysis, Cryolipolysis, Fat Reduction

Brief summary

The purpose of this study is to evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction with an alternative treatment parameter.

Detailed description

The study evaluated the use of the Zeltiq CooSculpting System for non-invasive fat removal in the flank.

Interventions

Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.

Sponsors

Zeltiq Aesthetics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male or female subjects \> 18 years of age and \< 65 years of age. 2. Subject has clearly visible fat on the flanks, which in the investigator's opinion, may benefit from the treatment. 3. Subject has not had weight change exceeding 10 pounds in the preceding month. 4. Subject with body mass index (BMI) up to 30. BMI is defined as weight in pounds multiplied by 703 divided by the square of the height in inches. 5. Subject agrees to maintain his/her weight (i.e., within 5 pounds) by not making any major changes in their diet or lifestyle during the course of the study. 6. Subject has read and signed a written informed consent form.

Exclusion criteria

1. Subject has had a surgical procedure(s) in the area of intended treatment. 2. Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy) in the area of intended treatment. 3. Subject has had a non-invasive fat reduction and/or body contouring procedure in the area of intended treatment within the past 12 months. 4. Subject needs to administer, or has a known history of subcutaneous injections into the area of intended treatment (e.g., heparin, insulin) within the past month. 5. Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria. 6. Subject has a known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin. 7. Subject has a history of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising. 8. Subject is taking or has taken diet pills or supplements within the past month. 9. Subject has any dermatological conditions, such as moderate to excessive skin laxity, or scars in the location of the treatment sites that may interfere with the treatment or evaluation (stretch marks is not an exclusion). 10. Subject has an active implanted device such as a pacemaker, defibrillator, or drug delivery system 11. Subject is pregnant or intending to become pregnant during the study period (in the next 5 months). 12. Subject is lactating or has been lactating in the past 6 months. 13. Subject has a history of hernia in the areas to be treated. 14. Subject is unable or unwilling to comply with the study requirements. 15. Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device. 16. Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

Design outcomes

Primary

MeasureTime frameDescription
The Number of Device and/or Procedure-Related Adverse EventsEnrollment through 16 weeks post-treatment visit, which is approximately 5 monthsThe number of device- or procedure-related adverse events will be tabulated. Adverse event reports are collected throughout the study from enrollment through the 16 week follow-up visit. The investigator determines if there is a relationship between the event and the study device or procedure.
Change in the Fat Layer of the Treated Area as Measured by UltrasoundPre-treatment and 16 weeks post-treatmentChange in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device, and in the untreated contralateral flank control area. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Overall fat layer thickness changes were normalized for each subject by subtracting the change in control from the change in treated area to remove the influence of weight variations. Success is defined as, on average, at least a 1mm or greater reduction in fat layer thickness for the treated flank as compared to the untreated control flank. Results indicate the fat layer reduction in millimeters.

Secondary

MeasureTime frameDescription
Proportion of Pre-treatment Images Correctly Identified.16 weeks post-treatmentChange in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images. Images show both treated and untreated flanks. Reviewers will be practicing dermatologists or plastic surgeons. Reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatments; subject has complete set of baseline photos and post-treatment photos; photos were taken using Zeltiq standard procedure. The expected success rate is 80% correct identification.
Subject Satisfaction16 weeks post-treatmentSubject satisfaction with the Zeltiq procedure as determined by the results of a subjects satisfaction questionnaire at the 16 week follow up visit. This questionnaire will be composed of 5-point Likert scale questions, as well as free-text responses.

Countries

Canada, United States

Participant flow

Recruitment details

Patients who seek reduction of fat in the flanks will be recruited from the general population.

Participants by arm

ArmCount
CoolSculpting Intervention
CoolSculpting treatments were performed on one (1) flank in a single treatment visit.
45
Total45

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicCoolSculpting Intervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
45 Participants
Age, Continuous44.1 years
Body Mass Index24.1 kg/m^2
Race/Ethnicity, Customized
African American
0 Participants
Race/Ethnicity, Customized
Asian
3 Participants
Race/Ethnicity, Customized
Caucasian
37 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants
Race/Ethnicity, Customized
Others
3 Participants
Region of Enrollment
Canada
25 participants
Region of Enrollment
United States
20 participants
Sex: Female, Male
Female
34 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 450 / 450 / 45
other
Total, other adverse events
7 / 4512 / 450 / 45
serious
Total, serious adverse events
0 / 450 / 450 / 45

Outcome results

Primary

Change in the Fat Layer of the Treated Area as Measured by Ultrasound

Change in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device, and in the untreated contralateral flank control area. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Overall fat layer thickness changes were normalized for each subject by subtracting the change in control from the change in treated area to remove the influence of weight variations. Success is defined as, on average, at least a 1mm or greater reduction in fat layer thickness for the treated flank as compared to the untreated control flank. Results indicate the fat layer reduction in millimeters.

Time frame: Pre-treatment and 16 weeks post-treatment

Population: Thirty-five subjects were included in the per-protocol analysis population: 1 subject was LTFU, 2 subjects did not complete the 16 week follow-up visit when ultrasonographer was present and 1 subject received an incomplete treatment. Six additional subjects had weight change greater than the protocol defined 5 pounds at the final follow-up visit.

ArmMeasureValue (MEAN)Dispersion
CoolSculpting of the Flank With Alternate Treatment ParametersChange in the Fat Layer of the Treated Area as Measured by Ultrasound-3.92 mmStandard Deviation 2.45
Comparison: H0: μ(Control - Treated) \< +1 versus H1: μ(Control - Treated) \> +195% CI: [3.08, 4.77]
Primary

The Number of Device and/or Procedure-Related Adverse Events

The number of device- or procedure-related adverse events will be tabulated. Adverse event reports are collected throughout the study from enrollment through the 16 week follow-up visit. The investigator determines if there is a relationship between the event and the study device or procedure.

Time frame: Enrollment through 16 weeks post-treatment visit, which is approximately 5 months

Population: The safety population includes all subjects treated with CoolSculpting.

ArmMeasureValue (NUMBER)
CoolSculpting of the Flank With Alternate Treatment ParametersThe Number of Device and/or Procedure-Related Adverse Events12 device or procedure-related AEs
Secondary

Proportion of Pre-treatment Images Correctly Identified.

Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images. Images show both treated and untreated flanks. Reviewers will be practicing dermatologists or plastic surgeons. Reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatments; subject has complete set of baseline photos and post-treatment photos; photos were taken using Zeltiq standard procedure. The expected success rate is 80% correct identification.

Time frame: 16 weeks post-treatment

Population: The study population consisted of 45 participants. 1 subject was lost to follow-up; 1 subject had an incomplete treatment and photos of 1 subject were poor quality. Of the remaining 42 subjects, 7 did not maintain weight per protocol. 35 sets of subject photos were included in the analysis. Each image showed both treated and untreated flanks; both arms were included in the photo review.

ArmMeasureValue (COUNT_OF_UNITS)
CoolSculpting of the Flank With Alternate Treatment ParametersProportion of Pre-treatment Images Correctly Identified.89 photos
95% CI: [0.784, 0.913]
Secondary

Subject Satisfaction

Subject satisfaction with the Zeltiq procedure as determined by the results of a subjects satisfaction questionnaire at the 16 week follow up visit. This questionnaire will be composed of 5-point Likert scale questions, as well as free-text responses.

Time frame: 16 weeks post-treatment

Population: Of the 45 study participants, one subject received incomplete treatment and did not complete the questionnaire and one subject was lost to follow-up. Free text responses and inconclusive responses were excluded from analysis.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionProcedure comfortable/very comfortable21 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionVery visible to visible fat reduction37 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionPositive overall effect34 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionSomewhat to very different fit of clothing26 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionSomewhat to very satisfied with procedure/results38 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionSomewhat likely to likely to have another procedur39 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionVery to somewhat likely to have same area treated24 Participants
CoolSculpting of the Flank With Alternate Treatment ParametersSubject SatisfactionWould recommend procedure to a friend37 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026